Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Renovorx Inc (RNXT)

Renovorx Inc (RNXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Renovorx Inc 2570 West El Camino Real Suite 320 Mountain View CA 94040 USA

www.renovorx.com Employees: 10 P: 650-284-4433 F: 650-397-4433

Sector:

Medical

Description:

RenovoRx Inc. is a biopharmaceutical company. It developed a therapy platform targeting difficult-to-treat tumors. RenovoRx Inc. is headquartered in Silicon Valley, California.

Key Statistics

Overview:

Market Capitalization, $K 41,415
Enterprise Value, $K 34,265
Shares Outstanding, K 36,650
Float, K 33,304
% Float 90.87%
Short Interest, K 617
Short Float 1.68%
Days to Cover 2.03
Short Volume Ratio 0.37
% of Insider Shareholders 9.13%
% of Institutional Shareholders 3.10%

Financials:

Annual Sales, $ 40 K
Annual Net Income, $ -8,810 K
Last Quarter Sales, $ 270 K
Last Quarter Net Income, $ -2,910 K
EBIT, $ -11,670 K
EBITDA, $ -11,670 K

Growth:

1-Year Return 7.00%
3-Year Return -67.58%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.08 on 11/13/25
Next Earnings Date 03/30/26 [AMC]
Earnings Per Share ttm -0.36
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 20.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

RNXT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -122.19%
Return-on-Assets % -90.69%
Profit Margin % -22,025.00%
Debt/Equity 0.00
Price/Sales 39.33
Price/Cash Flow N/A
Price/Book 5.26
Book Value/Share 0.22
Interest Coverage -0.77
60-Month Beta 1.34
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.